NASDAQ:AHCO AdaptHealth - AHCO Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $21.33 -0.05 (-0.23%) (As of 02/2/2023 12:00 AM ET) Add Compare Share Share Today's Range$21.12▼$21.9050-Day Range$19.02▼$22.8652-Week Range$11.40▼$27.48Volume842,708 shsAverage Volume622,378 shsMarket Capitalization$2.87 billionP/E Ratio49.60Dividend YieldN/APrice Target$27.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media AdaptHealth MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside29.7% Upside$27.67 Price TargetShort InterestBearish13.98% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 2 Articles This WeekInsider TradingSelling Shares$15.66 M Sold Last QuarterProj. Earnings Growth51.76%From $0.85 to $1.29 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.84 out of 5 starsMedical Sector33rd out of 1,030 stocksHome Health Care Services Industry3rd out of 9 stocks 3.5 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $27.67, AdaptHealth has a forecasted upside of 29.7% from its current price of $21.33.Amount of Analyst CoverageAdaptHealth has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted13.98% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.Change versus previous monthShort interest in AdaptHealth has recently decreased by 1.95%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 2.0 News and Social Media Coverage News SentimentAdaptHealth has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for AdaptHealth this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 2 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,661,578.00 in company stock.Percentage Held by Insiders17.30% of the stock of AdaptHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions86.33% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 4.4 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 51.76% in the coming year, from $0.85 to $1.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is 49.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.32.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is 49.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 162.36.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.47. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AdaptHealth (NASDAQ:AHCO) StockAdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.Read More Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address AHCO Stock News HeadlinesJanuary 26, 2023 | americanbankingnews.comBrokerages Set AdaptHealth Corp. (NASDAQ:AHCO) Price Target at $27.67January 10, 2023 | finance.yahoo.comAdaptHealth Provides Full-Year 2023 Guidance and Preliminary Commentary on Fourth Quarter 2022 ResultsFebruary 3, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! January 10, 2023 | finance.yahoo.comShould We Be Cautious About AdaptHealth Corp.'s (NASDAQ:AHCO) ROE Of 4.5%?December 23, 2022 | finance.yahoo.comAdaptHealth to Participate in JP Morgan Healthcare ConferenceDecember 21, 2022 | finance.yahoo.comHere's Why AdaptHealth (NASDAQ:AHCO) Has Caught The Eye Of InvestorsNovember 30, 2022 | finance.yahoo.comAdaptHealth Corp. (NASDAQ:AHCO) Not Lagging Market On Growth Or PricingNovember 30, 2022 | finance.yahoo.comAdaptHealth To Participate In BofA Securities Home Care ConferenceFebruary 3, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! November 10, 2022 | finance.yahoo.comAdaptHealth Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsNovember 8, 2022 | finance.yahoo.comAdaptHealth Posts Mixed Q3 Earnings, Revises Annual GuidanceOctober 20, 2022 | finance.yahoo.comAdaptHealth Corp. Announces Third Quarter 2022 Earnings Release Date and Conference CallOctober 18, 2022 | nasdaq.comPeek Under The Hood: QVMS Has 29% Upside - NasdaqOctober 18, 2022 | finance.yahoo.comShareholders in AdaptHealth (NASDAQ:AHCO) are in the red if they invested a year agoOctober 13, 2022 | technews.tmcnet.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of AdaptHealth Corp. (AHCO) and Encourages Long-Term AHCO Investors to Contact the FirmOctober 12, 2022 | finance.yahoo.comPaubox Announces Nine Native Hawaiian Recipients of its 2022 College Scholarship Program - Yahoo FinanceOctober 7, 2022 | nytimes.comTo Improve Students’ Mental Health, Schools Take a Team Approach - The New York TimesOctober 7, 2022 | cnn.comIn one North Carolina community, mental health workers respond to 911 calls - CNNOctober 5, 2022 | investors.comAdapthealth Corp Cl A Earns Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business DailySeptember 28, 2022 | benzinga.comWearable Medical Devices Revolutionize How Patient Data Can be Tracked - AdaptHealth (NASDAQ:AHCO), Garmi - BenzingaSeptember 23, 2022 | bizjournals.comSoaring 76 rankings 2022: Greater Philadelphia's fastest-growing companies, Nos. 2-25 - The Business JournalsSeptember 19, 2022 | uk.investing.comSusquehanna Slashes Price Target On NetApp, Plus Compass Point Boosts PT On This Stock By 75% By Benzinga - Investing.com UKSeptember 19, 2022 | seekingalpha.comAHCO stock named a Fresh Pick at Baird after investor day (NASDAQ:AHCO) - Seeking AlphaSeptember 19, 2022 | benzinga.comWhere AdaptHealth Stands With Analysts - AdaptHealth (NASDAQ:AHCO) - BenzingaSeptember 19, 2022 | markets.businessinsider.com4 Analysts Have This to Say About AdaptHealthSeptember 19, 2022 | markets.businessinsider.comWhere AdaptHealth Stands With AnalystsSeptember 17, 2022 | businesswire.comAdaptHealth Capital Markets Day to Highlight Progress Executing Strategy to Transform Healthcare by Keeping Patients Healthy at Home - Business WireSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address AHCO Company Calendar Last Earnings11/08/2022Today2/03/2023Next Earnings (Confirmed)2/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,700Year FoundedN/APrice Target and Rating Average Stock Price Forecast$27.67 High Stock Price Forecast$30.00 Low Stock Price Forecast$26.00 Forecasted Upside/Downside+29.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.43 Trailing P/E Ratio49.60 Forward P/E Ratio25.09 P/E Growth0.47Net Income$156.18 million Net Margins3.28% Pretax Margin4.43% Return on Equity4.38% Return on Assets1.78% Debt Debt-to-Equity Ratio1.00 Current Ratio1.35 Quick Ratio1.08 Sales & Book Value Annual Sales$2.45 billion Price / Sales1.17 Cash Flow$3.12 per share Price / Cash Flow6.84 Book Value$15.44 per share Price / Book1.38Miscellaneous Outstanding Shares134,730,000Free Float111,423,000Market Cap$2.87 billion OptionableNot Optionable Beta0.65 Key ExecutivesStephen P. GriggsChief Executive Officer & DirectorJoshua ParnesPresident & DirectorJason A. ClemensChief Financial & Accounting OfficerAlbert A. PrastChief Technology OfficerWendy RussalesiChief Compliance OfficerKey CompetitorsAmedisysNASDAQ:AMEDAddus HomeCareNASDAQ:ADUSLHC GroupNASDAQ:LHCGEnhabitNYSE:EHABOption Care HealthNASDAQ:OPCHView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 1,483 shares on 2/2/2023Ownership: 0.009%Zurcher Kantonalbank Zurich Cantonalbank Sold 2,532 shares on 2/1/2023Ownership: 0.007%Everence Capital Management Inc.Bought 11,070 shares on 1/31/2023Ownership: 0.008%Sumitomo Mitsui Trust Holdings Inc.Bought 59,972 shares on 1/30/2023Ownership: 2.210%New York State Common Retirement FundBought 1,145 shares on 1/30/2023Ownership: 0.270%View All Insider TransactionsView All Institutional Transactions AHCO Stock - Frequently Asked Questions Should I buy or sell AdaptHealth stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AHCO shares. View AHCO analyst ratings or view top-rated stocks. What is AdaptHealth's stock price forecast for 2023? 5 equities research analysts have issued 1 year target prices for AdaptHealth's stock. Their AHCO share price forecasts range from $26.00 to $30.00. On average, they anticipate the company's share price to reach $27.67 in the next year. This suggests a possible upside of 29.7% from the stock's current price. View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts. How have AHCO shares performed in 2023? AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO shares have increased by 11.0% and is now trading at $21.33. View the best growth stocks for 2023 here. When is AdaptHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023. View our AHCO earnings forecast. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) released its quarterly earnings results on Tuesday, November, 8th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.31 by $0.20. The firm had revenue of $756.50 million for the quarter, compared to analysts' expectations of $738.58 million. AdaptHealth had a net margin of 3.28% and a trailing twelve-month return on equity of 4.38%. What guidance has AdaptHealth issued on next quarter's earnings? AdaptHealth issued an update on its FY 2022 earnings guidance on Friday, January, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.98 billion-$2.98 billion, compared to the consensus revenue estimate of $2.98 billion. What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS). What is AdaptHealth's stock symbol? AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO." Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (2.21%), Reinhart Partners Inc. (0.37%), LGT Capital Partners LTD. (0.32%), Scout Investments Inc. (0.31%), New York State Common Retirement Fund (0.27%) and New York State Teachers Retirement System (0.06%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AdaptHealth's stock price today? One share of AHCO stock can currently be purchased for approximately $21.33. How much money does AdaptHealth make? AdaptHealth (NASDAQ:AHCO) has a market capitalization of $2.87 billion and generates $2.45 billion in revenue each year. The company earns $156.18 million in net income (profit) each year or $0.43 on an earnings per share basis. How many employees does AdaptHealth have? The company employs 10,700 workers across the globe. How can I contact AdaptHealth? AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com. This page (NASDAQ:AHCO) was last updated on 2/3/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.